Want to see SDGR full AI Analyst Report?
SDGR Stock Chart & Stats
$19.99
-$0.16(-1.06%)
At close: 4:00 PM EDT
$19.99
-$0.16(-1.06%)
Day’s Range― - ―
52-Week Range$10.95 - $33.78
Previous CloseN/A
Volume981.72K
Average Volume (3M)2.87M
Market Cap
$1.78B
Enterprise Value$920.43M
Total Cash (Recent Filing)$413.74M
Total Debt (Recent Filing)$107.98M
Price to Earnings (P/E)―
Beta1.87
Next Earnings
Nov 04, 2026EPS Estimate
-0.67Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.74
Shares Outstanding65,641,430
10 Day Avg. Volume1,740,980
30 Day Avg. Volume2,871,509
Financial Highlights & Ratios
PEG Ratio0.28
Price to Book (P/B)3.61
Price to Sales (P/S)5.13
P/FCF Ratio105.42
Enterprise Value/Market Cap0.52
Enterprise Value/Revenue3.55
Enterprise Value/Gross Profit6.25
Enterprise Value/Ebitda-19.98
Forecast
1Y Price Target
$26.20Price Target Upside31.07% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)-1.64
Revenue Forecast (FY)$241.47M
Bulls Say, Bears Say
Bulls Say
Recurring ACV GrowthGrowth across quarterly, first-half, and trailing ACV measures indicates broadening customer commitments to Schrödinger’s platform. This recurring contract momentum can support more predictable software revenue, deepen account relationships, and provide a durable base for future product expansion.
Platform And Product ExpansionThe Bunsen launch extends Schrödinger’s platform into agentic AI-enabled scientific workflows while strategic deployments and technology partnerships broaden reach. If customer use scales, throughput-based licensing and a wider user base could reinforce platform relevance and diversify growth.
Strong Financial FlexibilityModerate leverage and a meaningful equity base provide financial flexibility as Schrödinger invests in software development and drug discovery programs. This capital structure reduces balance-sheet strain relative to heavier borrowing, although continued losses still require disciplined resource allocation.
Bears Say
Persistent Losses And Cash BurnNegative operating and free cash flow show that the business is not yet consistently self-funding, despite strong revenue growth. Continued cash burn can constrain investment capacity over time and makes progress toward sustainable profitability dependent on improved operating leverage.
Hosted Transition Revenue PressureThe planned hosted transition supports a different licensing model but creates a multi-period revenue-recognition headwind as more contracts are recognized ratably. This can obscure underlying adoption, moderate reported growth, and complicate execution while the business moves toward its hosted target.
Slow New-Product AdoptionExtended evaluation and validation cycles delay broad commercialization of newer products, even when early demand and pilot contributions are present. The slower ramp can defer meaningful revenue and ACV benefits, placing greater near-term reliance on established offerings and collaborations.
Schrodinger News
SDGR FAQ
What was Schrodinger’s price range in the past 12 months?
Schrodinger lowest stock price was $10.95 and its highest was $33.78 in the past 12 months.
What is Schrodinger’s market cap?
Schrodinger’s market cap is $1.78B.
When is Schrodinger’s upcoming earnings report date?
Schrodinger’s upcoming earnings report date is Nov 04, 2026 which is in 10 days.
How were Schrodinger’s earnings last quarter?
Schrodinger released its earnings results on Aug 05, 2026. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of -$0.414 by $0.494.
Is Schrodinger overvalued?
According to Wall Street analysts Schrodinger’s price is currently Undervalued.
Does Schrodinger pay dividends?
Schrodinger does not currently pay dividends.
What is Schrodinger’s EPS estimate?
Schrodinger’s EPS estimate is -0.67.
How many shares outstanding does Schrodinger have?
Schrodinger has 65,641,430 shares outstanding.
What happened to Schrodinger’s price movement after its last earnings report?
Schrodinger reported an EPS of $0.08 in its last earnings report, beating expectations of -$0.414. Following the earnings report the stock price went up 8.598%.
Which hedge fund is a major shareholder of Schrodinger?
Currently, no hedge funds are holding shares in SDGR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Schrodinger Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$26.20 (31.07% Upside)
$26.20 (31.07% Upside)
Blogger Sentiment
Bullish
SDGR Sentiment 60%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Decreased
By 35.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.7%
Last 30 Days ▲ 13.3%
Last 30 Days ▲ 13.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
8.37%
12-Months-Change
Fundamentals
Return on Equity
-16.37%
Trailing 12-Months
Asset Growth
-6.95%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Schrodinger
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
SDGR Company Deck
SDGR Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational momentum driven by robust ACV growth, accelerating hosted adoption, the early launch and customer deployment of Bunsen, notable one-time collaboration milestones (e.g., $10M Ajax milestone) and a return to quarterly profitability with a solid cash position. Counterbalancing this optimism are near-term margin and revenue recognition pressures from the accelerated hosted licensing transition, a decline in contribution revenue tied to grant timing, and multi-quarter adoption timelines for new products like predictive toxicology. Guidance shows moderate full-year ACV growth (10%–15%), reflecting a more conservative outlook than Q2’s run-rate. Overall, positives around product innovation, customer expansion, and financial position outweigh the transitional challenges while leaving some execution and timing risks to monitor.View all SDGR earnings summariesSDGR Stock 12 Month Forecast
Average Price Target
$26.20
▲(31.07% Upside)
Technical Analysis
Ownership Overview
3.61% Insiders
17.42% Mutual Funds
0.68% Other Institutional Investors
50.87% Public Companies and
Individual Investors